LB Pharmaceuticals (LBRX) IPO deck
LB Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative therapies for schizophrenia, bipolar depression, and other neuropsychiatric disorders.
LB Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative therapies for schizophrenia, bipolar depression, and other neuropsychiatric disorders.
%20IPO%20deck){kind=link}